JiHoon Kang - Concepedia

Author

JiHoon Kang

University of Ulsan ORCID

Also Known As

J Kang, J. H. Kang, J. Kang, Ji-hoon Kang, JiHoon Kang, Jia Min Kang, Jihoon Kang, Kang J, Youn-Jung Kim

118

Publications

Citations

H-Index

Concepts

All Affiliations

University of Ulsan Asan Medical Center Ulsan College Pusan National University Sungkyunkwan University

About

JiHoon Kang is an author at University of Ulsan specializing in medicine, radiation oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	811
2	Health Sciences	3	3	98
3	Natural Sciences	2	2	42
4	Public Health	1	1	80
5	Social Sciences	1	1	46

JiHoon Kang

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis JiHoon Kang, Inhwan Hwang, Changhoon Yoo, Investigational New Drugs OncologyPancreatic CancerGastrointestinal OncologyMedicineGemcitabine Versus Folfirinox	2018	144
PAK1 Tyrosine Phosphorylation Is Required to Induce Epithelial–Mesenchymal Transition and Radioresistance in Lung Cancer Cells EunGi Kim, HyeSook Youn, TaeWoo Kwon, Cancer Research Emt BlockadeInduce Epithelial–mesenchymal TransitionPak1 Tyrosine PhosphorylationCancer BiologyTumor Biology	2014	82
TFAP2C increases cell proliferation by downregulating GADD45B and PMAIP1 in non-small cell lung cancer cells Hyunhee Do, Dain Kim, JiHoon Kang, Biological Research	2019	80
Neutrophil‐to‐lymphocyte ratio and risk of lung cancer mortality in a low‐risk population: A cohort study JiHoon Kang, Yoosoo Chang, Jiin Ahn, International Journal of Cancer EpidemiologyCancer RiskCancer EpidemiologyLung Cancer MortalityMedicine	2019	80
TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation JiHoon Kang, Won Jung Kim, Sang Yeoup Lee, Oncogene MedicineBronchial NeoplasmMicrorna DetectionTumor SuppressorCancer Genetics	2016	74
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib Chung Ryul Oh, Sun‐Young Kong, Hyeon-Su Im, BMC Cancer	2019	65
DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN–WEE1 Signaling Jie Li, Chaoyun Pan, Austin C. Boese, Clinical Cancer Research	2020	60
Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1 Chaoyun Pan, JiHoon Kang, Jung Seok Hwang, Nature Communications	2021	59
PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells Wanyeon Kim, HyeSook Youn, TaeWoo Kwon, Pharmacological Research Tumor BiologyOncologyMedicinePim1 Kinase InhibitorsBronchial Neoplasm	2013	53
Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells JiHoon Kang, Wanyeon Kim, TaeWoo Kwon, Oncotarget Emt MarkersRadiation MedicineOncologyMedicineFunctional Communication	2016	53

Page 1